Connect with us

Technology

AI Impact on Electron Microscope Market growth, set to increase by USD 1.72 billion from 2024-2028, Rising need for root-cause failure analysis to boost the revenue, Technavio

Published

on

NEW YORK, Aug. 22, 2024 /PRNewswire/ — The global electron microscope market  size is estimated to grow by USD 1.72 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about 8.09%  during the forecast period.  Rising need for root-cause failure analysis is driving market growth, with a trend towards increased demand for lvems. However, high product cost and heavy excise duties  poses a challenge. Key market players include Advantest Corp., Agilent Technologies Inc., Bruker Corp., Carl Zeiss AG, COXEM Co. Ltd., Danaher Corp., DELONG INSTRUMENTS AS, Hirox Co. Ltd., HOVERLABS, JEOL Ltd., Keysight Technologies Inc., Nikon Corp., Nion, Novartis AG, Olympus Corp., Seiko Holdings Corp., TESCAN GROUP, Thermo Fisher Scientific Inc., Topcon Corp., and UNISOKU Co. Ltd..

Get a detailed analysis on regions, market segments, customer landscape, and companies – Click for the snapshot of this report

Forecast period

2024-2028

Base Year

2023

Historic Data

2018 – 2022

Segment Covered

Application (Semiconductors, Life sciences, Material sciences, and Nanotechnology), Technology (SEM, TEM, and DBEM), End-user (Industries, Institutions, and Others), and Geography (APAC, North America, Europe, Middle East and Africa, and South America)

Region Covered

APAC, North America, Europe, Middle East and Africa, and South America

Key companies profiled

Advantest Corp., Agilent Technologies Inc., Bruker Corp., Carl Zeiss AG, COXEM Co. Ltd., Danaher Corp., DELONG INSTRUMENTS AS, Hirox Co. Ltd., HOVERLABS, JEOL Ltd., Keysight Technologies Inc., Nikon Corp., Nion, Novartis AG, Olympus Corp., Seiko Holdings Corp., TESCAN GROUP, Thermo Fisher Scientific Inc., Topcon Corp., and UNISOKU Co. Ltd.

Key Market Trends Fueling Growth

The electron microscope market is witnessing significant growth due to the increasing demand for low-voltage electron microscopes (LVEMs), particularly in life sciences, material science, pathology, and nanomaterials applications. LVEMs operate at a lower voltage (less than 25kV) than high-voltage electron microscopes (HVEMs), making them suitable for installation in any lab. Their advantages include being compact, cost-effective, and causing minimal damage to specimens, especially those with a low atomic number. LVEMs, such as Delong America’s LVEM5 and LVEM25, offer multiple modes and can function as a TEM, SEM, STEM, or DBEM. Although LVEMs have lower magnification capabilities compared to HVEMs, their affordability and versatility make them an essential addition to research facilities. Technavio anticipates the global electron microscope market to continue expanding due to the rising demand for these innovative microscopes. 

The Electron Microscope market is thriving with trends like digital microscopy and high-resolution imaging. Improvements in image resolution help eliminate distorted images, ensuring better quality control. Open-source software and closed-source software are popular choices for skilled professionals in various industries. Neuronstudio and L-measure are leading software solutions. Physicists and laboratory technicians in sectors like surface physics, surface analyses, and nanotechnology research use these microscopes for magnification, depth of field, and topographical, morphological, compositional information. Industries like gemology, metallurgy, pharmaceutical and biotechnology, semiconductor and electronics, textiles, natural resources, aeronautics, automotive, apparel, pharmaceutical, industrial failure analysis, process control, and life science rely on Electron Microscopes for their specific needs. Super-resolution microscopy, artificial intelligence-based imaging, and correlative microscopy are the latest advancements. Trade regulations ensure safety and ethical use. Electron Microscopes are essential scientific instruments for disease diagnostics, biological sciences, healthcare facilities, and alternative imaging technologies. 

Discover a Comprehensive 360° Market Analysis: Understand the Impact of AI. For detailed information- Request Sample!

Market Challenges

The electron microscope market involves significant upfront costs, making sales to research institutions heavily reliant on government and corporate funding. This funding, however, is subject to change and can create market uncertainty. Additionally, import duties and taxes, such as customs duties, levied by various governments on electron microscopes add to the final product price. These taxes serve as revenue generation strategies for governments. In some countries, the same government that funds research institutions imposes these taxes. The taxation can take the form of direct or indirect taxes, with rates varying from 11% in the US to 17% in Brazil. An increase in taxes and duties raises the overall cost of electron microscopes, potentially hindering market growth during the forecast period.The Electron Microscope Market is experiencing significant growth, particularly in the Lifesciences segment. Scanning electron microscopes (SEMs) are driving innovation, with educational institutions and nanotech research leading the way. Funding for nanotechnology, semiconductors, material sciences, and life sciences is increasing, fueling the development of new nanomaterials and nanotechnology-based devices. Challenges include the need for high resolution power, advanced features like surface topography analysis, and the involvement of quality control personnel. The semiconductor industry relies on electron microscopes for failure analysis, detection, and lithography. Nanotechnology applications include imaging at the atomic scale, and the development of new microscopes like cryo-electron microscopy, digitization, and live-cell imaging. Rising technological advancements are leading to super resolution, high throughput methods, expansion microscopes, scanning helium microscopes, and multi-view microscopes. Clinical trials, pathology, diagnosis of diseases like toxicology and forensics, immune electron microscopy, and cryo-electron microscopy are all benefiting from these advancements. The market is expected to continue expanding as new applications and integrated microscopy workflows emerge.

For more insights on driver and challenges – Download a Sample Report

Segment Overview 

This electron microscope market report extensively covers market segmentation by

Application 1.1 Semiconductors1.2 Life sciences1.3 Material sciences1.4 NanotechnologyTechnology 2.1 SEM2.2 TEM2.3 DBEMEnd-user 3.1 Industries3.2 Institutions3.3 OthersGeography 4.1 APAC4.2 North America4.3 Europe4.4 Middle East and Africa4.5 South America

1.1 Semiconductors-  The Electron Microscope Market has experienced steady growth due to increasing demand from various industries such as semiconductor, materials science, and biotechnology. These microscopes provide high-resolution images, enabling advancements in research and development. Key players include FEI Company, JEOL Ltd., and Carl Zeiss AG, who invest in innovation and expansion to meet market needs. The market’s future looks promising with ongoing technological advancements and growing applications.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2018 – 2022)  – Download a Sample Report

Research Analysis

The Electron Microscope Market is experiencing significant growth, particularly in the Lifesciences segment, driven by the increasing demand for high-resolution imaging in research and development. Scanning electron microscopes (SEMs) are a popular choice due to their ability to provide detailed images of various surfaces, including skinny wafers in the semiconductor industry and nanotech research. Product innovation is a key factor in the market’s expansion, with new technologies such as expansion microscopes, scanning helium microscopes, and multi-view microscopes gaining popularity. High throughput methods and integrated microscopy workflows are also driving efficiency and productivity in the market. Digital microscopy and image resolution continue to be important areas of focus, with advancements in technology helping to minimize distorted images. Import-Export Analysis reveals that the market is global in nature, with key application niches including biologics and transmission electron microscopes. The integration of Artificial Intelligence (AI) and Machine Learning (ML) is also transforming the market, enabling faster and more accurate image analysis.

Market Research Overview

The Electron Microscope Market is witnessing significant growth due to the rising technological advancement in various industries, particularly in the lifesciences segment. Scanning electron microscopes (SEMs) are gaining popularity for their ability to provide high-resolution images of surface topography and morphological, compositional information at the atomic scale. Nanotech research, semiconductors, material sciences, and nanomaterials are some key areas driving the market’s growth. Product innovation is a major trend, with new features such as digitization, live-cell imaging, super resolution, high throughput methods, expansion microscopes, scanning helium microscopes, multi-view microscopes, and integrated microscopy workflows. Educational institutions are also investing in electron microscopes for research and teaching purposes. Funding for nanotechnology-based research and development is another growth driver, particularly in the areas of nanotechnology, lithography, coating, failure analysis, detection, semiconductor devices, and nanotechnology-based devices. The market caters to various industries, including lifesciences, pharmaceutical and biotechnology, semiconductor and electronics, textiles, natural resources industries, aeronautics, automotive, apparel, and industrial failure analysis. Quality control personnel in these industries rely on electron microscopes for surface physics and surface analyses, magnification, depth of field, and high-resolution imaging. The market also offers open-source and closed-source software solutions such as Neuronstudio and L-measure, which are preferred by skilled professionals, including physicists and laboratory technicians. The market’s growth is further fueled by the increasing demand for atomic force scanning, cryo-electron microscopy, and correlative microscopy in fields such as gemology, metallurgy, and forensics. Clinical trials, pathology, diagnosis of diseases, toxicology, and immune electron microscopy are some other applications driving the market’s growth. Despite the market’s potential, challenges such as distorted images, quality control, and the high cost of electron microscopes and associated equipment remain. However, ongoing research and development efforts are addressing these challenges, ensuring the market’s continued growth.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ApplicationSemiconductorsLife SciencesMaterial SciencesNanotechnologyTechnologySEMTEMDBEMEnd-userIndustriesInstitutionsOthersGeographyAPACNorth AmericaEuropeMiddle East And AfricaSouth America

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-impact-on-electron-microscope-market-growth-set-to-increase-by-usd-1-72-billion-from-2024-2028–rising-need-for-root-cause-failure-analysis-to-boost-the-revenue-technavio-302228627.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING

Published

on

By

NEW YORK, May 5, 2026 /PRNewswire/ — Vernal Capital Acquisition Corp. (NYSE: VECA) (“Vernal”) announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at $10.00 per unit. The units are expected to trade on the New York Stock Exchange (“NYSE”) under “VECAU” beginning May 6, 2026. Each unit consists of one ordinary share and one right to receive one-fourth of one ordinary share upon consummation of an initial business combination. Upon separate trading, the ordinary shares and rights are expected to be listed on NYSE under “VECA” and “VECAR,” respectively.

D. Boral Capital LLC is acting as sole book-running manager of the offering. The underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover any over-allotments. The offering is expected to close on May 7, 2026, subject to customary closing conditions.

A registration statement for these securities was declared effective by the SEC on May 5, 2026. The offering is made only by means of a prospectus. Copies of the prospectus may be obtained, from D. Boral Capital LLC, 590 Madison Ave., 39th Floor, New York, New York 10022, by telephone at (212) 970-5150 or by email at dbccapitalmarkets@dboralcapital.com.

This press release shall not constitute an offer to sell or to buy, nor shall there be any sale where such offer, solicitation or sale would be unlawful prior to registration or qualification under the applicable securities laws.

About Vernal

Vernal is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Vernal’s target search will not be limited to a particular industry or geographic region.

Forward-Looking Statements

This press release contains “forward-looking statements,” including statements regarding Vernal’s IPO. These statements are subject to risks and uncertainties that could cause actual results to differ materially. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, beyond Vernal’s control, including those in the Risk Factors section of Vernal’s registration statement filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Vernal disclaims any obligation to release publicly updates or revisions to any forward-looking statements to reflect any change in Vernal’s expectations, except as required by law.

Contact

Binghan Yi, CFO
binghan@vernal.com
www.vernalspac.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vernal-capital-acquisition-corp-announces-pricing-of-100-million-initial-public-offering-302763378.html

SOURCE Vernal Capital Acquisition Corp.

Continue Reading

Technology

RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America

Published

on

By

Nomination places the Charlottesville-based company among growth-stage medtech leaders recognized for commercial momentum in AI-powered clinical decision support; public voting is open through May 8

CHARLOTTESVILLE, Va., May 5, 2026 /PRNewswire/ — RIVANNA®, developer of AI-powered clinical decision-support solutions, today announced that it has been nominated for MedTech Scale-Up of the Year at the MedTech World Awards 2026 | North America. Public voting is open through Friday, May 8, 2026, with category winners to be announced at the inaugural North American Awards Gala on May 11, 2026, at the Hilton West Palm Beach in Florida.

The MedTech Scale-Up of the Year category honors a growth-stage company successfully scaling revenues, partnerships, and adoption across the global medical technology ecosystem. Nominees across the program’s 22 categories were selected through a structured process led by the MedTech World Steering Committee, with category winners determined by a combination of expert evaluation and public voting from the global MedTech community.

“We have built RIVANNA on validation earned from the most rigorous technical buyers in healthcare: competitive federal awards translated into FDA-cleared products, each paired with a commercial program that meets clinicians where they work,” said Will Mauldin, PhD, Co-founder and CEO of RIVANNA. “Being nominated for MedTech Scale-Up of the Year is a meaningful affirmation of that approach and the team executing it.”

Public voting closes Friday, May 8, 2026. Members of the MedTech community are invited to support RIVANNA’s nomination at the official voting page: vote here.

The award nomination follows a year of measurable scaling for RIVANNA:

In October 2025, RIVANNA reported on being named a finalist in MedTech Innovator’s 2025 Early-Stage Grand Prize competition, selected from nearly 1,500 global applicants to represent the top 4% of medtech innovations worldwide.In December 2025, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of its Accuro® 3S Needle Guide Kit consumables, building on existing Accuro 3S device clearance.In April 2026, RIVANNA reported on peer-reviewed findings, published in 2025 in the Journal of Emergency Medicine (DOI: 10.1016/j.jemermed.2025.11.011), showing that the Accuro® XV musculoskeletal imaging system enables non-physician operators to acquire diagnostic-quality scans after just one hour of hands-on training.In May 2026, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of the Accuro® XV Diagnostic Ultrasound System for musculoskeletal imaging, authorizing commercial use across hospital and clinic settings.The company’s clinical program now spans eight sites nationwide with more than 1,500 patients enrolled.

The 2026 MedTech World Awards | North America, powered by Blue Goat Cyber, will be presented Monday, May 11, 2026, at the inaugural North American Awards Gala at the Hilton West Palm Beach, marking the first time the MedTech World Awards have been hosted in the United States.

About the MedTech Scale-Up of the Year Award
Presented by MedTech World, the MedTech Scale-Up of the Year category recognizes growth-stage medical technology companies demonstrating strong commercial momentum, expanding partnerships, and accelerating real-world adoption. The award is one of 22 categories spanning innovation, clinical excellence, regulatory strategy, investment, and leadership across the global MedTech ecosystem.

About RIVANNA
RIVANNA® is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company’s platform automates complex anatomical analysis at the point of care, enabling faster, more confident clinical decisions while reducing variability and expanding access to advanced capabilities. The first applications target significant market opportunities in regional anesthesia and fracture care. RIVANNA has built a proven FDA regulatory track record across its Accuro® platform, with device clearances for Accuro® 3S (spinal needle guidance) and Accuro® XV (musculoskeletal imaging), a portfolio of supporting cleared consumables, and AI software modules advancing through regulatory review. The company is backed by 100+ patents and validated through clinical partnerships with leading academic medical centers. RIVANNA is headquartered in Charlottesville, Virginia, and operates an FDA-registered, ISO 13485:2016-certified manufacturing facility. Learn more at rivannamedical.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rivanna-nominated-for-medtech-scale-up-of-the-year-at-medtech-world-awards-2026–north-america-302763342.html

SOURCE RIVANNA

Continue Reading

Technology

D2L Launch Week Highlights Latest Product Releases

Published

on

By

Latest innovations are designed to save time, simplify workflows, and help drive better learning outcomes

TORONTO, May 5, 2026 /PRNewswire/ – D2L, a global leader in learning innovation, hosted its first-ever D2L Launch Week, a four-day virtual webinar series spotlighting the company’s latest product innovations across D2L Brightspace in 2026.

Throughout the week, D2L showcased a range of product releases through live demos and practical customer use cases, highlighting how institutions, school districts and organizations can help to drive engagement and improve learning outcomes. The featured updates include enhancements to D2L Lumi for idea generation, intervention suggestions, quiz creation and summarization; tools to strengthen parent and guardian outreach; and administrative capabilities designed to help large organizations delegate course and configuration management more effectively.

“We’re proud to showcase the ways D2L continues to innovate to help make learning more personalized, efficient, and scalable,” said Christian Pantel, Chief Product Officer at D2L. “From new D2L Lumi features to enhanced communication tools and more flexible distributed administration capabilities, these updates are designed to help our customers save time, improve usability, and deliver better learning experiences at scale.”

Enhancements to D2L Lumi

Among the new capabilities were several updates to D2L’s AI-native tool, D2L Lumi, designed to improve usability, transparency, and alignment across workflows, including:

D2L Lumi Ideas: Generates assignment and discussion ideas directly within Brightspace, making it easier to generate high quality content aligned to learning outcomes.D2L Lumi Insights: Gives educators access to learning intervention suggestions, designed to provide recommended next steps based on learner data.D2L Lumi Quiz: Helps educators generate questions from multiple course content topics and includes a more streamlined question-generation workflow.D2L Lumi Summary: Supports summarization from more content sources, including nested submodules, and can give educators the ability to preview and adjust source text before summarization.

Updates to Parent and Guardian Communications

D2L also introduced new parent and guardian communication enhancements to help K-12 educators strengthen engagement beyond the classroom. Teachers can now send bulk emails to all parents and guardians associated with students in their class. For individual student outreach, teachers can also email parents and guardians of a specific learner, making it easier to share timely updates on student progress and classroom activity.

Manage Distributed Administration at Scale

Distributed Administration gives organizations more flexibility to delegate administrative responsibilities across organization levels. With Distributed Administration, administrators can manage specific areas, enabling them to oversee courses while helping to reduce bottlenecks and free up time.

Learn more about the latest product releases showcased at D2L Launch Week.

About D2L   
D2L is transforming the way the world learns, helping learners achieve more than they dreamed possible. Working closely with customers all over the world, D2L is on a mission to make learning more inspiring, engaging and human. Find out how D2L helps transform lives and delivers outstanding learning outcomes in K-12, higher education and businesses.

D2L Media Contact
PR@D2L.com
X: @D2L
© 2026 D2L Corporation.

The D2L family of companies includes D2L Inc., D2L Corporation, D2L Ltd, D2L Australia Pty Ltd, D2L Europe Ltd, D2L Asia Pte Ltd, D2L India Pvt Ltd, D2L Brasil Soluções de Tecnologia para Educação Ltda and D2L Sistemas de Aprendizaje Innovadores, S. D2 R.L de C.V., and H5P Group AS.

All D2L and H5P marks are owned by the D2L group of companies. Please visit D2L.com/trademarks for a list of D2L marks. All other trademarks are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/d2l-launch-week-highlights-latest-product-releases-302763345.html

SOURCE D2L

Continue Reading

Trending